QuidelOrtho Corporation (QDEL) Q4 2025 Earnings Call February 11, 2026 5:00 PM EST
Company Participants
Juliet Cunningham – Vice President of Investor Relations
Brian Blaser – President, CEO & Director
Jonathan Siegrist – Executive VP of Research & Development and CTO
Joseph Busky – Chief Financial Officer
Conference Call Participants
Tycho Peterson – Jefferies LLC, Research Division
Jack Meehan – Nephron Research LLC
Andrew Brackmann – William Blair & Company L.L.C., Research Division
Patrick Donnelly – Citigroup Inc., Research Division
Lu Li – UBS Investment Bank, Research Division
Andrew Cooper – Raymond James & Associates, Inc., Research Division
Casey Woodring – JPMorgan Chase & Co, Research Division
William Bonello – Craig-Hallum Capital Group LLC, Research Division
Presentation
Operator
Good morning or good afternoon. Welcome to the QuidelOrtho Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast. [Operator Instructions] Please note this conference call is being recorded. An audio replay of the conference call will be available on the company’s website shortly after this call.
I would now like to turn the call over to Juliet Cunningham, Vice President of Investor Relations. Thank you.
Juliet Cunningham
Vice President of Investor Relations
Thank you. Good afternoon, everyone. Thanks for joining us. With me today are Brian Blaser, President and Chief Executive Officer; Jonathan Siegrist, Chief Technology Officer; and Joe Busky, Chief Financial Officer. This conference call is being simultaneously webcast on the Investor Relations page of our website. To assist in the presentation, we also posted supplemental information on our IR page that will be referenced throughout this call. This conference call and supplemental information contains forward-looking statements, which are made as of today, February 11, 2026. We assume no obligation to update any forward-looking statement, except as required by law.
Statements that are not strictly historical, including the company’s expectations, plans, financial guidance, future performance and prospects are forward-looking statements
